Legend Biotech (LEGN) Change in Inventory (2020 - 2026)
Legend Biotech's (LEGN) quarterly Change in Inventory came in at $700000.0 in Q1 2026, up 121.88% YoY from $315493.0 in Q1 2025, and down 86.97% on a QoQ basis from $5.4 million in Q3 2025.
Analysis
Legend Biotech (LEGN) Change in Inventory (2020 - 2026) Analysis & Trends
Legend Biotech (LEGN) has 7 years of Change in Inventory data on file, last reported at $700000.0 in Q1 2026.
- Quarterly Change in Inventory rose 121.88% year-over-year to $700000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $53000.0 (up 100.33% YoY) and the FY2024 annual result came in at -$17.2 million, down 35.43% from the prior year.
- Change in Inventory retreated to $700000.0 in Q1 2026, from $5.4 million in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $5.4 million in Q3 2025 to a low of -$8.6 million in Q4 2022.
- A 5-year average of -$2.9 million and a median of -$3.2 million in 2023 frame the typical range for Change in Inventory.
- Annual changes were most pronounced in 2022 — Change in Inventory slumped 7382.61% — and 2025, when it surged 205.75%.
- Tracing LEGN's Change in Inventory over 5 years: stood at -$8.6 million in 2022, then soared by 56.98% to -$3.7 million in 2023, then tumbled by 69.23% to -$6.3 million in 2024, then soared by 185.76% to $5.4 million in 2025, then sank by 86.97% to $700000.0 in 2026.
- The last three Change in Inventory figures came in at $700000.0 (Q1 2026), $5.4 million (Q3 2025), and -$2.8 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 132.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 47.15 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -280,000.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 12.97 Mn |
| 10 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn | -6.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -6.00 Mn |
| Mar 31, 2026 | 700,000.00 |
| Dec 31, 2025 | -3.85 Mn |
| Sep 30, 2025 | 5.35 Mn |
| Jun 30, 2025 | -2.80 Mn |
| Mar 31, 2025 | -3.20 Mn |
| Dec 31, 2024 | -6.26 Mn |
| Sep 30, 2024 | -5.08 Mn |
| Jun 30, 2024 | -1.39 Mn |
| Mar 31, 2024 | -4.47 Mn |
| Dec 31, 2023 | -3.70 Mn |
| Sep 30, 2023 | -3.59 Mn |
| Jun 30, 2023 | -3.25 Mn |
| Mar 31, 2023 | -2.17 Mn |
| Dec 31, 2022 | -8.61 Mn |
| Sep 30, 2022 | -2.27 Mn |
| Jun 30, 2022 | -5.26 Mn |
| Mar 31, 2022 | -1.15 Mn |
| Dec 31, 2021 | -115,000.00 |
| Sep 30, 2021 | 72,000.00 |